Gaudium IVF and Women Health Ltd (GAUDIUMIVF) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 544709 | NSE: GAUDIUMIVF | Hospital & Healthcare Services |

Gaudium IVF & Women Share Price

75.63 -3.94 -4.95%
as on 06-Mar'26 16:59

DeciZen - make an informed investing decision on Gaudium IVF & Women

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Gaudium IVF and Women Health stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
29.62
Market Cap:
550.5 Cr.
52-wk low:
75.6
52-wk high:
87.2

Is Gaudium IVF and Women Health Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Gaudium IVF & Women: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Gaudium IVF and Women Health Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 82.7%76.5%45.4%49.3%-
Value Creation
Index
4.94.52.22.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 36.54445.95959
Sales YoY Gr.-20.5%4.4%28.4%-
Adj EPS 1.52.21.632.6
YoY Gr.-46%-25%87%-
BVPS (₹) 1.63.74.37.428.3
Adj Net
Profit
9.113.39.918.619
Cash Flow from Ops. 0243.58.4-
Debt/CF from Ops. 00.44.52.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA17.3%28.4%
Adj EPS NANA27%87%
BVPSNANA68%70.5%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
95.181.940.151.614.3
Op. Profit
Mgn %
37.844.941.147.6NAN
Net Profit
Mgn %
24.930.121.631.531.5
Debt to
Equity
0.60.40.60.4-
Working Cap
Days
075911750
Cash Conv.
Cycle
013491070

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Gaudium IVF and Women Health Ltd.

Standalone Consolidated
TTM EPS (₹) 2.6 2.6
TTM Sales (₹ Cr.) 59 70.7
BVPS (₹.) 28.3 28.4
Reserves (₹ Cr.) 169 170
P/BV 2.68 2.67
PE 29.62 28.78
From the Market
52 Week Low / High (₹) 75.60 / 87.15
All Time Low / High (₹) 76.46 / 87.15
Market Cap (₹ Cr.) 550
Equity (₹ Cr.) 36.4
Face Value (₹) 5
Industry PE 85.7

Management X-Ray of Gaudium IVF & Women:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Gaudium IVF & Women - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Gaudium IVF & Women

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales37444659
Operating Expenses 23242731
Manufacturing Costs3566
Material Costs4545
Employee Cost 4667
Other Costs 1181012
Operating Profit 14201928
Operating Profit Margin (%) 37.8%44.9%41.1%47.6%
Other Income 0000
Interest 1012
Depreciation 1122
Exceptional Items 0000
Profit Before Tax 12181625
Tax 3566
Profit After Tax 9131019
PAT Margin (%) 24.9%30.1%21.6%31.5%
Adjusted EPS (₹)1.52.21.63.0
Dividend Payout Ratio (%)0%48%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 10232745
Share Capital 11131
Reserves 9222615
Minority Interest0000
Debt6101619
Long Term Debt2222
Short Term Debt381417
Trade Payables1111
Others Liabilities 4279
Total Liabilities 21355175

Fixed Assets

Gross Block7202022
Accumulated Depreciation3424
Net Fixed Assets 4161818
CWIP 0007
Investments 0116
Inventories0123
Trade Receivables611424
Cash Equivalents 215127
Others Assets 81411
Total Assets 21355175

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 02438
PBT 0181625
Adjustment 0233
Changes in Working Capital 09-14-15
Tax Paid 0-5-2-5
Cash Flow From Investing Activity 0-14-5-15
Capex 0-13-3-9
Net Investments 00-0-5
Others 0-1-2-1
Cash Flow From Financing Activity 04-12
Net Proceeds from Shares 0000
Net Proceeds from Borrowing 0-0-0-0
Interest Paid 0-0-1-1
Dividend Paid 00-60
Others 0463
Net Cash Flow 013-3-5

Finance Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)95.1381.8840.1251.56
ROCE (%)82.776.4745.4149.31
Asset Turnover Ratio1.771.581.070.94
PAT to CFO Conversion(x)01.850.30.42
Working Capital Days
Receivable Days633058115
Inventory Days371213
Payable Days114919183

Gaudium IVF and Women Health Ltd Stock News

Gaudium IVF and Women Health Ltd FAQs

The current trading price of Gaudium IVF & Women on 06-Mar-2026 16:59 is ₹75.63.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 05-Mar-2026 the market cap of Gaudium IVF & Women stood at ₹550.5.
The latest P/E ratio of Gaudium IVF & Women as of 05-Mar-2026 is 29.62.
The latest P/B ratio of Gaudium IVF & Women as of 05-Mar-2026 is 2.68.
The 52-week high of Gaudium IVF & Women is ₹87.15 and the 52-week low is ₹75.60.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Gaudium IVF & Women is ₹59.00 ( Cr.) .

About Gaudium IVF and Women Health Ltd

Gaudium IVF and Women Health was originally incorporated in the name of ‘Gaudium IVF and Women Health Private Limited’ as a private limited company on March 24, 2015. Subsequently, the company was converted from a private limited company into a public limited company pursuant to a special resolution passed in the extraordinary general meeting of the shareholders held on September 28, 2024 and consequently, the name of the company was changed to ‘Gaudium IVF and Women Health Limited’.

The company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. The company has patients from different countries such as Canada, United Kingdom, United State, Kenya, South Africa and Oman. The company’s Main centers (Hubs) are located in major cities to cater potential locations across India.

The company offers a complete array of specialized fertility and reproductive health services. Its advance treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction, all its treatments are carefully designed to address a variety of infertility challenges for both male and female. The company also offers comprehensive gynaecological care, including PCOD/PCOS and endometriosis. Further, high-risk pregnancy management is provided for women with complex fertility histories or health conditions. The wellness aspect includes fertility wellness programs, offering nutritional counselling and psychological support to ensure holistic care for couples undergoing treatments.

Business area of the company 

The company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. The company has patients from different countries such as Canada, United Kingdom, United State, Kenya, South Africa and Oman. The company’s Main centers (Hubs) are located in major cities to cater potential locations across India.

Services of the company

Fertility Treatment

  • IVF treatment, or in vitro fertilization
  • Intrauterine Insemination (IUI)
  • Intracytoplasmic Sperm Injection (ICSI)
  • Polycystic Ovarian Syndrome (PCOS), also known as polycystic ovarian disease (PCOD)
  • Male Infertility
  • Endometriosis Treatment
  • Ovulation Induction (OI)
  • Laser Assisted Embryo Implantation
  • Infertility Surgeries
  • Surrogacy

Hospital Facility

Pharmacy service

Awards, accreditations and recognition 

  • 2016: Asia's Greatest Brand.
  • 2018: Symbol of Brand Excellence Award.
  • 2019: India Best Practices Award- IVF Chain Company of the Year.
  • 2022: Highly Prestigious Quality Choice Award.
  • 2023: Holistic Healthcare Brand Leader of the Year.

History and milestones

  • 2015: Incorporation of the company.
  • 2019: The company started Gaudium Hospital.
  • 2021: Acquired the Gaudium IVF & Gynae Solutions, Proprietor Business of Dr. Manika Khanna: Janakpuri Center (opened in 2009), Greater Kailash Center (opened in 2016), Patna Center (opened in 2019).
  • 2021: The company started Mumbai Center (Maharashtra).
  • 2023: Acquired Gaudium Brand.
  • 2023: Acquired 100% shares of Gaudium International Private Limited.
  • 2023: Acquired Gaudium Bawa Ludhiana Center.
  • 2023: The company started Bangalore Centre (Karnataka).
  • 2024: The company started Srinagar Centre (Jammu & Kashmir).
  • 2024: Conversion of company from Private to Public.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×